Skip to content

News

Action Alert: Cosponsor Johanna’s Law Reauthorization (H.R. 4560)

Action Alert: Cosponsor Johanna’s Law Reauthorization (H.R. 4560)

We need your help to strengthen critical gynecologic cancer education and awareness programs. (October 16, 2019) Recently, Rep. Rosa DeLauro (D-CT)—leader of the Congressional Ovarian Cancer Caucus and an ovarian cancer survivor herself—introduced HR 4560, legislation to reauthorize Johanna’s Law, also known as The Gynecologic Cancer Education and Awareness Act. Johanna’s Law supports a variety … Continued

Action Alert: Tell Senate – More Funding for Ovarian Cancer Research!

Action Alert: Tell Senate – More Funding for Ovarian Cancer Research!

(April 3, 2019) We have one week to let the Senate know that we need more funding for ovarian cancer research! Thanks to your efforts, a record 158 U.S. House members signed a Dear Colleague letter calling for more funding for the Ovarian Cancer Research Program (OCRP) at the Department of Defense. Now we need … Continued

Update on $15 Million Increase Request for OCRP Funding

Update on $15 Million Increase Request for OCRP Funding

(April 1, 2019) 156 House Members have joined Reps. DeLauro and Duffy in a call for increased ovarian cancer research funding. Reps. Rosa DeLauro (D-CT) and Sean Duffy (R-WI) – co-chairs of the Congressional Ovarian Cancer Caucus – today delivered a “Dear Colleague” letter to the House Defense Appropriations Subcommittee requesting a $15 million increase in … Continued

OCRA Spring Advocacy Day 2019 Actions

OCRA Spring Advocacy Day 2019 Actions

(March 20, 2019) Earlier this month, OCRA united advocates from across the country for Spring Advocacy Day on Capitol Hill. Together, this passionate group of survivors, caregivers and supporters used their collective voice to advocate for increased funding for ovarian cancer research and education. Learn more about our asks for Ovarian Cancer Research Program (OCRP) … Continued

Action Alert: Tell Congress to Increase OCRP Funding

Action Alert: Tell Congress to Increase OCRP Funding

(March 19, 2019) Congress is considering a $15 million increase for OCRP funding. Urge YOUR Representative to sign the letter to help push this funding through. Deadline is March 25th! The Ovarian Cancer Research Program (OCRP) is a cutting-edge program housed within the Department of Defense and despite a history of successful breakthroughs, the program … Continued

OCRA’s Advocate Leader Program is now open. Apply today.

OCRA’s Advocate Leader Program is now open. Apply today.

Be a voice for the ovarian cancer community. Update: The deadline to apply for our 2019 Advocate Leader program has now passed. (August 28, 2018) Registration is now open for our 2019 Advocate Leader program. Apply today to join our diverse community of survivors, caregivers and activists from across the country using their voices to effect … Continued

Meet Sayla, OCRA Advocate Leader

Meet Sayla, OCRA Advocate Leader

Name: Sayla H.Hometown: Portland, ORStatus: In treatmentAdvocacy Goal: Oral Parity, Access to Care Sayla was diagnosed earlier last year and is currently in treatment. She’s determined to use her experience to help other women, and is empowered to advocate for women fighting ovarian cancer through OCRA’s Advocate Leader program. Tell us about your ovarian cancer … Continued

Meet Elise, OCRA Advocate Leader

Meet Elise, OCRA Advocate Leader

Name: Elise D.Hometown: Durham, NHStatus: 13-Year SurvivorAdvocacy Goal: Access to Care Elise feels lucky that she was diagnosed with early-stage ovarian cancer, and being an Advocate Leader allows her to fight for women who may not be able to fight for themselves. Tell us about your ovarian cancer journey. In the summer of 2005, I … Continued

OCRFA’s Response to Trump Administration’s Birth Cont...

OCRFA’s Response to Trump Administration’s Birth Control Coverage Rollback

(Oct. 11, 2017) Last week, the Trump Administration issued a regulation to immediately allow employers to deny insurance coverage for birth control on the basis of their own moral or religious objections, undermining the landmark benefit under the Affordable Care Act (ACA) that guarantees coverage for contraception without co-pays or cost-sharing. Audra Moran, President and … Continued

Dept. of Health and Human Services Seeks to Limit Access to...

Dept. of Health and Human Services Seeks to Limit Access to Oral Contraception Benefits

According to recent reports, the Department of Health and Human Services (HHS) will soon seek to limit access to oral contraception benefits. “The proposed rule allowing employers to deny insurance coverage for birth control limits the application of oral contraceptives in preventive medicine, in particular, for ovarian cancer. Oral contraceptives have been shown to reduce … Continued

Action Alert: Protect Federal Funding for Ovarian Cancer Re...

Action Alert: Protect Federal Funding for Ovarian Cancer Research

The White House has released a proposed budget for FY2018 that makes drastic cuts to the budgets for the National Institute of Health (NIH) and Centers for Disease Control and Prevention (CDC). These cuts would reduce the NIH budget by 20% and threaten to halt breakthrough medical research advancements and delay life-saving cures. The proposed … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.